M&A Deal Summary

Teligent Acquires Alveda Pharmaceuticals

On November 16, 2015, Teligent acquired distribution company Alveda Pharmaceuticals for 47M CAD

Acquisition Highlights
  • This is Teligent’s 1st transaction in the Distribution sector.
  • This is Teligent’s 0th largest (disclosed) transaction.
  • This is Teligent’s 2nd transaction in Canada.
  • This is Teligent’s 2nd transaction in Ontario.

M&A Deal Summary
Date 2015-11-16
Target Alveda Pharmaceuticals
Sector Distribution
Buyer(s) Teligent
Deal Type Add-on Acquisition
Deal Value 47M CAD

Target

Alveda Pharmaceuticals

Toronto, Ontario, Canada
Alveda Pharmaceuticals, Inc. is specializing in the sale and distribution of quality pharmaceuticals. Alveda Pharmaceuticals was founded in Toronto, Ontario.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Teligent

Buena, New Jersey, United States
Category Company
Founded 1977
Sector Life Science
Employees252
Revenue 66M USD (2019)
DESCRIPTION

Teligent manufactures, fills and packages topical semi?solid and liquid products for cosmetic, cosmeceutical and pharmaceutical customers. Teligent’s products are used for cosmetic, cosmeceutical and prescription applications for the treatment of symptoms of dermatitis, acne, psoriasis, and eczema. Teligent was founded in 1977 and is based in Buena, New Jersey.

DEAL STATS #
Overall 2 of 2
Sector (Distribution) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Ontario) 2 of 2
Country (Canada) 2 of 2
Year (2015) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-10-05 Concordia Pharmaceuticals - Frotaz Zinacef ad Zantac Injection

Oakville, Ontario, Canada

Fortaz®, ZinacefTM, and Zantac® Injection are the products used in specialty generic pharma.

Buy $10M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-01-17 Teligent - Sterile Injectable Assets

Mississauga, Ontario, Canada

Teligent's Sterile Injectable Assets includes a portfolio of 25 sterile injectable products, three in-licensed ophthalmic products, and a pipeline of seven additional products. Teligent's Sterile Injectable Assets are based in Mississauga, Ontario.

Sell $46M
Mergr

Product

Company

Legal